ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 4623

$922K Total Retail Price of All Prescriptions

Rank: 185 out of 4623

700 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 700 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

23% of this provider’s 700 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 18,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,215 1,091 1 2
LEVOTHYROXINE SODIUM 1,112 1,035 2 1
OMEPRAZOLE 970 880 3 7
LOSARTAN POTASSIUM 844 786 4 21
HYDROCODONE-ACETAMINOPHEN 688 472 S3 5 3
PRAVASTATIN SODIUM 684 586 6 11
AMLODIPINE BESYLATE 501 447 7 5
METFORMIN HCL 456 414 8 6
FENOFIBRATE 422 386 9 54
GLIMEPIRIDE 412 353 10 38
FUROSEMIDE 391 373 11 8
LISINOPRIL 337 288 12 4
LOSARTAN-HYDROCHLOROTHIAZIDE 332 313 13 46
CARVEDILOL 321 287 14 25
BENAZEPRIL HCL 305 260 15 70
LOVASTATIN 302 300 16 34
METOPROLOL TARTRATE 299 282 17 9
ATELVIA 273 261 18 217
TRAMADOL HCL 270 232 19 15
ATENOLOL 251 224 20 28
METOPROLOL SUCCINATE 247 209 21 13
HYDROCHLOROTHIAZIDE 231 198 22 10
CRESTOR 207 173 23 20
ATORVASTATIN CALCIUM 206 177 24 12
TAMSULOSIN HCL 184 181 25 29
DONEPEZIL HCL 184 184 25 30
ACTOS 183 160 27 87
RAMIPRIL 181 169 28 76
GABAPENTIN 176 131 29 16
SERTRALINE HCL 167 151 30 26
ZOLPIDEM TARTRATE 167 133 30 18
CIPROFLOXACIN HCL 148 136 32 43
LANTUS 148 135 32 44
INSULIN SYRINGE 146 128 34 85
PROAIR HFA 145 116 35 64
PAROXETINE HCL 145 143 35 78
WARFARIN SODIUM 144 144 37 24
POTASSIUM CHLORIDE 134 123 38 14
GLYBURIDE 128 116 R 39 59
GLIPIZIDE 125 123 40 49
ENALAPRIL MALEATE 124 107 41 41
CAPTOPRIL 116 108 42 215
FLUTICASONE PROPIONATE 115 107 43 32
SINGULAIR 114 107 44 83
VERAPAMIL ER 110 90 45 96
PLAVIX 107 100 46 45
LIDODERM 105 79 47 139
CLONIDINE HCL 94 87 48 40
MECLIZINE HCL 93 76 49 125
NIFEDIPINE ER 92 85 50 97
MEGESTROL ACETATE 92 78 R 50 145
DILTIAZEM ER 91 86 52 179
CLOPIDOGREL 89 86 53 31
AMOXICILLIN 87 63 54 95
CELEBREX 84 79 55 89
EXFORGE 82 80 56 181
DIOVAN 80 79 57 39
NIASPAN 79 79 58 110
NEXIUM 79 55 58 17
IBUPROFEN 78 66 60 65
HYDROXYZINE HCL 76 73 R 61 138
LACTULOSE 75 74 62 106
DOXAZOSIN MESYLATE 74 74 63 98
ACTONEL 74 72 63 165
LANTUS SOLOSTAR 72 55 65 105
RANITIDINE HCL 72 72 65 47
MONTELUKAST SODIUM 71 66 67 158
ALENDRONATE SODIUM 71 71 67 22
DIGOXIN 69 69 69 58
PANTOPRAZOLE SODIUM 68 54 70 35
HUMALOG 68 57 70 186
METFORMIN HCL ER 66 66 72 51
ISOSORBIDE MONONITRATE ER 64 53 73 60
PEN NEEDLE 63 54 74 122
NAMENDA 62 62 75 36
VESICARE 62 61 75 166
ESCITALOPRAM OXALATE 62 58 75 75
CITALOPRAM HBR 60 55 78 23
FINASTERIDE 60 60 78 109
CLOBETASOL PROPIONATE 59 54 80 277
AZITHROMYCIN 58 51 81 33
JANUVIA 58 47 81 52
PIOGLITAZONE HCL 57 47 R 83 230
CYCLOBENZAPRINE HCL 54 30 R 84 53
ALLOPURINOL 53 51 85 37
PROMETHAZINE HCL 52 39 R 86 93
AVODART 50 44 87 172
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.